- Home
- EQS vs CCM Comparison
EQS vs CCM Comparison
Compare EQS & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EQS | CCM |
|---|---|---|
| Founded | 1991 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 19.0M |
| IPO Year | 1995 | 2009 |
Fundamental Metrics
Financial Performance| Metric | EQS | CCM |
|---|---|---|
| Price | $1.20 | $4.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.6K | ★ 44.5K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.07 | $3.18 |
| 52 Week High | $2.49 | $6.98 |
Technical Indicators
Market Signals| Indicator | EQS | CCM |
|---|---|---|
| Relative Strength Index (RSI) | 45.88 | 58.89 |
| Support Level | $1.11 | $4.41 |
| Resistance Level | $2.03 | $5.38 |
| Average True Range (ATR) | 0.06 | 0.50 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 50.00 | 67.35 |
Price Performance
Historical ComparisonAbout EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. The company invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.